Under the settlement, Glenmark gets to launch a generic Zetia in Dec 2016, only four months before the expiration of the challenged patent in Apr 2017. Glenmark evidently did not like its chances in a patent trial.
A side question: Will anyone still be using Zetia in 2017?
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”